Filing Details

Accession Number:
0001209191-14-018000
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-06 18:06:50
Reporting Period:
2014-03-05
Filing Date:
2014-03-06
Accepted Time:
2014-03-06 18:06:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949699 Pharmacyclics Inc PCYC Pharmaceutical Preparations (2834) 943148201
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1507649 Gregory Hemmi C/O Pharmacyclics, Inc.
995 East Arques Avenue
Sunnyvale CA 94085
Sr. Vp Chemical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-03-05 15,000 $0.86 53,004 No 4 M Direct
Common Stock Disposition 2014-03-05 15,000 $140.00 38,004 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-03-05 15,000 $0.00 15,000 $0.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
88,515 2008-03-18 2018-03-18 No 4 M Direct
Footnotes
  1. Option granted under the issuer's 2004 Equity Incentive Award Plan in a transaction exempt under rule 16b-3(d). Option shares are fully vested.